206 related articles for article (PubMed ID: 23182396)
1. The adoption of new adjuvant radiation therapy modalities among Medicare beneficiaries with breast cancer: clinical correlates and cost implications.
Roberts KB; Soulos PR; Herrin J; Yu JB; Long JB; Dostaler E; Gross CP
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1186-92. PubMed ID: 23182396
[TBL] [Abstract][Full Text] [Related]
2. Quantifying institutional resource utilization of adjuvant brachytherapy and intensity-modulated radiation therapy for endometrial cancer via time-driven activity-based costing.
Ning MS; Klopp AH; Jhingran A; Lin LL; Eifel PJ; Vedam S; Lawyer AA; Olivieri ND; Guzman AB; Incalcaterra JR; Mesko SM; Pezzi TA; Boyce-Fappiano DR; Shaitelman SF; Frank SJ; Thaker NG
Brachytherapy; 2019; 18(4):445-452. PubMed ID: 30992185
[TBL] [Abstract][Full Text] [Related]
3. Intensity modulated radiation therapy following lumpectomy in early-stage breast cancer: Patterns of use and cost consequences among Medicare beneficiaries.
Halasz LM; Patel SA; McDougall JA; Fedorenko C; Sun Q; Goulart BHL; Roth JA
PLoS One; 2019; 14(9):e0222904. PubMed ID: 31568536
[TBL] [Abstract][Full Text] [Related]
4. Examining the cost-effectiveness of radiation therapy among older women with favorable-risk breast cancer.
Sen S; Wang SY; Soulos PR; Frick KD; Long JB; Roberts KB; Yu JB; Evans SB; Chagpar AB; Gross CP
J Natl Cancer Inst; 2014 Mar; 106(3):dju008. PubMed ID: 24598714
[TBL] [Abstract][Full Text] [Related]
5. Cost implications of the rapid adoption of newer technologies for treating prostate cancer.
Nguyen PL; Gu X; Lipsitz SR; Choueiri TK; Choi WW; Lei Y; Hoffman KE; Hu JC
J Clin Oncol; 2011 Apr; 29(12):1517-24. PubMed ID: 21402604
[TBL] [Abstract][Full Text] [Related]
6. A cost comparison analysis of adjuvant radiation therapy techniques after breast-conserving surgery.
Lanni T; Keisch M; Shah C; Wobb J; Kestin L; Vicini F
Breast J; 2013; 19(2):162-7. PubMed ID: 23294184
[TBL] [Abstract][Full Text] [Related]
7. Time-driven activity-based cost comparison of prostate cancer brachytherapy and intensity-modulated radiation therapy.
Dutta SW; Bauer-Nilsen K; Sanders JC; Trifiletti DM; Libby B; Lash DH; Lain M; Christodoulou D; Hodge C; Showalter TN
Brachytherapy; 2018; 17(3):556-563. PubMed ID: 29519605
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Radiation Oncologists on the Early Adoption of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer.
Boero IJ; Gillespie EF; Hou J; Paravati AJ; Kim E; Einck JP; Yashar C; Mell LK; Murphy JD
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):571-580. PubMed ID: 28126306
[TBL] [Abstract][Full Text] [Related]
9. Adoption of hypofractionated radiation therapy for breast cancer after publication of randomized trials.
Jagsi R; Falchook AD; Hendrix LH; Curry H; Chen RC
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1001-9. PubMed ID: 25539365
[TBL] [Abstract][Full Text] [Related]
10. Adoption of intensity modulated radiation therapy for early-stage breast cancer from 2004 through 2011.
Wang EH; Mougalian SS; Soulos PR; Smith BD; Haffty BG; Gross CP; Yu JB
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):303-11. PubMed ID: 25442334
[TBL] [Abstract][Full Text] [Related]
11. Intensity-Modulated Radiation Therapy in Breast Cancer Patients Following the Release of a Choosing Wisely Recommendation.
Torres MA; Gogineni K; Howard DH
J Natl Cancer Inst; 2020 Mar; 112(3):314-317. PubMed ID: 31647560
[TBL] [Abstract][Full Text] [Related]
12. For-profit hospital ownership status and use of brachytherapy after breast-conserving surgery.
Sen S; Soulos PR; Herrin J; Roberts KB; Yu JB; Lesnikoski BA; Ross JS; Krumholz HM; Gross CP
Surgery; 2014 May; 155(5):776-88. PubMed ID: 24787104
[TBL] [Abstract][Full Text] [Related]
13. The early adoption of intensity-modulated radiotherapy and stereotactic body radiation treatment among older Medicare beneficiaries with prostate cancer.
Jacobs BL; Yabes JG; Lopa SH; Heron DE; Chang CH; Schroeck FR; Bekelman JE; Kahn JM; Nelson JB; Barnato AE
Cancer; 2017 Aug; 123(15):2945-2954. PubMed ID: 28301689
[TBL] [Abstract][Full Text] [Related]
14. Trends in the utilization of adjuvant vaginal cuff brachytherapy and/or external beam radiation treatment in stage I and II endometrial cancer: a surveillance, epidemiology, and end-results study.
Patel MK; Cote ML; Ali-Fehmi R; Buekers T; Munkarah AR; Elshaikh MA
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):178-84. PubMed ID: 22014953
[TBL] [Abstract][Full Text] [Related]
15. Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis.
Sher DJ; Neville BA; Chen AB; Schrag D
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e197-206. PubMed ID: 21596483
[TBL] [Abstract][Full Text] [Related]
16. Trends in Local Therapy Utilization and Cost for Early-Stage Breast Cancer in Older Women: Implications for Payment and Policy Reform.
Shirvani SM; Jiang J; Likhacheva A; Hoffman KE; Shaitelman SF; Caudle A; Buchholz TA; Giordano SH; Smith BD
Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):605-16. PubMed ID: 27034179
[TBL] [Abstract][Full Text] [Related]
17. National variation in the delivery of radiation oncology procedures in the non-facility-based setting.
Valle LF; Chu FI; Kundu P; Yoon SM; Gilchrist T; Steinberg ML; Raldow AC
Cancer Med; 2021 Jul; 10(14):4734-4742. PubMed ID: 34076341
[TBL] [Abstract][Full Text] [Related]
18. Cost of Intensity-modulated Radiation Therapy for Older Patients with Stage III Lung Cancer.
Kale MS; Mhango G; Bonomi M; Federman A; Sigel K; Rosenzweig KE; Wisnivesky JP
Ann Am Thorac Soc; 2016 Sep; 13(9):1593-9. PubMed ID: 27299697
[TBL] [Abstract][Full Text] [Related]
19. Clinical Effectiveness of an Adaptive Treatment Planning Algorithm for Intensity Modulated Radiation Therapy Versus 3D Conformal Radiation Therapy for Node-Positive Breast Cancer Patients Undergoing Regional Nodal Irradiation/Postmastectomy Radiation Therapy.
Bazan JG; Healy E; Beyer S; Kuhn K; DiCostanzo D; Smith TL; Jhawar S; White JR
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1159-1171. PubMed ID: 32711036
[TBL] [Abstract][Full Text] [Related]
20. Trends and variations in utilization and costs of radiotherapy for prostate cancer: A SEER medicare analysis from 2007 through 2016.
Mukherjee K; Small W; Duszak R
Brachytherapy; 2022; 21(1):12-21. PubMed ID: 34380592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]